1. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006; 101:2379–2400.
Article
2. Uhl W, Warshaw A, Imrie C, et al. IAP guidelines for the surgical management of acute pancreatitis. Pancreatology. 2002; 2:565–573.
Article
3. Pandol SJ, Saluja AK, Imrie CW, Banks PA. Acute pancreatitis: bench to the bedside. Gastroenterology. 2007; 132:1127–1151.
Article
4. Bradley EL III. Atlanta redux. Pancreas. 2003; 26:105–106.
5. Vege SS, Gardner TB, Chari ST, et al. Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include “moderately severe acute pancreatitis”. Am J Gastroenterol. 2009; 104:710–715.
Article
6. Bollen TL, Besselink MG, van Santvoort HC, et al. Toward an update of the Atlanta classi. cation on acute pancreatitis: review of new and abandoned terms. Pancreas. 2007; 35:107–113.
7. Bollen TL, van Santvoort HC, Besselink MG, et al. The Atlanta Classification of acute pancreatitis revisited. Br J Surg. 2008; 95:6–21.
Article
8. Morgan DE. Imaging of acute pancreatitis and its complications. Clin Gastroenterol Hepatol. 2008; 6:1077–1085.
Article
9. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974; 139:69–81.
10. Imrie CW. Classification of acute pancreatitis and the role of prognostic factors in assessing severity of disease. Schweiz Med Wochenschr. 1997; 127:798–804.
11. Johnson CD, Toh SK, Campbell MJ. Combination of APACHE-II score and obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Pancreatology. 2004; 4:1–6.
12. Ogawa M, Hirota M, Hayakawa T, et al. Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas. 2002; 25:325–330.
Article
13. Drew PJ, Monson JR. Artificial neural networks. Surgery. 2000; 127:3–11.
Article
14. Mofidi R, Powell TI, Brabazon A, et al. Prediction of the exact degree of internal carotid artery stenosis using an artificial neural network based on duplex velocity measurements. Ann Vasc Surg. 2005; 19:829–837.
Article
15. Mofidi R, Deans C, Duff MD, de Beaux AC, Paterson Brown S. Prediction of survival from carcinoma of oesophagus and oesophagogastric junction following surgical resection using an artificial neural network. Eur J Surg Oncol. 2006; 32:533–539.
Article
16. Halonen KI, Leppäniemi AK, Lundin JE, Puolakkainen PA, Kemppainen EA, Haapiainen RK. Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models. Pancreatology. 2003; 3:309–315.
Article
17. Mofidi R, Duff MD, Madhavan KK, Garden OJ, Parks RW. Identification of severe acute pancreatitis using an artificial neural network. Surgery. 2007; 141:59–66.
Article
18. Wu BU, Johannes RS, Sun X, et al. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008; 57:1698–1703.
Article
19. Singh VK, Wu BU, Bollen TL, et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009; 104:966–971.
Article
20. Ueda T, Takeyama Y, Yasuda T, et al. Simple scoring system for the prediction of the prognosis of severe acute pancreatitis. Surgery. 2007; 141:51–58.
Article
21. Lee BJ, Kim CD, Jung SW, et al. Analysis of the factors that affect the mortality rate in severe acute pancreatitis. Korean J Gastroenterol. 2008; 51:25–33.
22. Lankisch PG, Weber-Dany B, Hebel K, Maisonneuve P, Lowenfels AB. The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of nonsevere disease. Clin Gastroenterol Hepatol. 2009; 7:702–705.
Article
23. Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas. 2000; 20:367–372.
Article
24. Remes-Troche JM, Duarte-Rojo A, Morales G, Robles-Diaz G. Hemoconcentration is a poor predictor of severity in acute pancreatitis. World J Gastroenterol. 2005; 11:7018–7023.
Article
25. Brown A, James-Stevenson T, Dyson T, Grunkenmeier D. The Panc 3 score: a rapid and accurate test for predicting severity on presentation in acute pancreatitis. J Clin Gastroenterol. 2007; 41:855–858.
26. Wu BU, Johannes RS, Conwell DL, Banks PA. Early hemoconcentration predicts increased mortality only among transferred patients with acute pancreatitis. Pancreatology. 2009; 9:639–643.
Article
27. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg. 1990; 77:1260–1264.
Article
28. Sandberg AA, Borgstrom A. Early prediction of severity in acute pancreatitis. Is this possible? JOP. 2002; 3:116–125.
29. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 2000; 355:1955–1960.
Article
30. Wu BU, Johannes RS, Sun X, Conwell DL, Banks PA. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology. 2009; 137:129–135.
Article
31. Muddana V, Whitcomb DC, Khalid A, Slivka A, Papachristou GI. Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis. Am J Gastroenterol. 2009; 104:164–170.
Article
32. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 2000; 47:546–552.
Article
33. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg. 1996; 83:919–923.
Article
34. Mentula P, Kylänpää ML, Kemppainen E, et al. Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg. 2005; 92:68–75.
Article
35. Kylänpää-Bäck ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen K, Repo H. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg. 2001; 88:222–227.
Article
36. Modrau IS, Floyd AK, Thorlacius-Ussing O. The clinical value of procalcitonin in early assessment of acute pancreatitis. Am J Gastroenterol. 2005; 100:1593–1597.
Article
37. Hedström J, Korvuo A, Kenkimäki P, et al. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet. 1996; 347:729–730.
38. Lempinen M, Kylänpää-Bäck ML, Stenman UH, et al. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin Chem. 2001; 47:2103–2107.
Article
39. Balthazar EJ. CT diagnosis and staging of acute pancreatitis. Radiol Clin North Am. 1989; 27:19–37.
40. Balthazar EJ. Staging of acute pancreatitis. Radiol Clin North Am. 2002; 40:1199–1209.
Article
41. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990; 174:331–336.
Article
42. Simchuk EJ, Traverso LW, Nukui YM, Kozarek RA. Computed tomography severity index is a predictor of outcomes for severe pancreatitis. Am J Surg. 2000; 179:352–355.
Article
43. Mortele KJ, Wiesner W, Intriere L, et al. A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. AJR Am J Roentgenol. 2004; 183:1261–1265.
Article